Precipio, Inc. (PRPO)
NASDAQ: PRPO · IEX Real-Time Price · USD
5.54
+0.44 (8.63%)
At close: Jul 26, 2024, 4:00 PM
5.75
+0.21 (3.79%)
After-hours: Jul 26, 2024, 7:04 PM EDT
Precipio Employees
As of December 31, 2023, Precipio had 57 total employees, including 51 full-time and 6 part-time employees. The number of employees increased by 1 or 1.79% compared to the previous year.
Employees
57
Change (1Y)
1
Growth (1Y)
1.79%
Revenue / Employee
$277,404
Profits / Employee
-$86,000
Market Cap
8.14M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Telesis Bio | 147 |
iCoreConnect | 70 |
Sunshine Biopharma | 44 |
NeuroMetrix | 26 |
Pulmatrix | 22 |
Sonoma Pharmaceuticals | 10 |
Shuttle Pharmaceuticals Holdings | 8 |
Tenax Therapeutics | 6 |
PRPO News
- 1 day ago - Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven - GlobeNewsWire
- 9 days ago - Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 - GlobeNewsWire
- 6 weeks ago - Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders - GlobeNewsWire
- 6 weeks ago - Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting - GlobeNewsWire
- 2 months ago - Precipio Secures a short-term $500K Credit Facility - GlobeNewsWire
- 4 months ago - Precipio Announces Year end 2023 Shareholder Update Call - GlobeNewsWire
- 5 months ago - Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY - GlobeNewsWire
- 6 months ago - Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer - GlobeNewsWire